Skip to content
Fencer Intel
critical 9.8

CVE-2015-3954 json

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, versio…

published 7y ago modified 4mo ago also EUVD-2015-3985

cvss
9.8
version 3.0, NVD
cisa kev
Not listed
not in CISA's catalog
epss
2.0%
EPSS 2.0% chance of exploitation in 30 days, percentile 81%
public exploits
0
none known

Summary

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Is CVE-2015-3954 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-15-161-01 updated cvss 10.0

Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities

  • Hospira Plum A+ Infusion System <=13.4 Hospira Plum A+3 Infusion System <=13.6 Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. Accordi <=3.13
    affected: mitigation “For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

2.04% chance of exploitation in the next 30 days, higher than 81% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
NVD 3.0 9.8 CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD 2.0 10.0 AV:N/AC:L/Au:N/C:C/I:C/A:C

Affected products

  • Hospira Plum A+ Infusion System
  • Hospira Plum A+3 Infusion System
  • Hospira Symbiq Infusion System

Classification

Weakness

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.